GlaxoSmithKline (JOBS), Takeda Pharmaceutical Co. Ltd.'s Diabetes Drug Double Women's Fracture Risk
LONDON (Reuters) - Long-term use of GlaxoSmithKline's Avandia and Takeda's Actos doubles the risk of bone fractures in women with type 2 diabetes, according to a study released on Wednesday. Scientists already knew the two thiazolidinedione (TZD) drugs for diabetes were associated with fractures, but the magnitude of the risk had not been evaluated.